Blood Cancer United

Blood Cancer United Doing the most for more people with blood cancer. We are Blood Cancer United, and we believe everyone with blood cancer deserves a longer, better life. How?

The Leukemia & Lymphoma Society is now Blood Cancer United.

šŸ’» www.bloodcancerunited.org
Community Guidelines šŸ‘‰ https://bit.ly/45LPmE0
Fundraiseā¤ļø https://www.facebook.com/fund/BloodCancerUnited/ That’s why we are on a mission to find a cure and improve the quality of life for everyone with blood cancer. We fund life-saving blood cancer research around the world, provide free information and suppo

rt services for patients and their families, and are the voice for those seeking access to quality, affordable, coordinated care. With your help, we have invested more than $1.8 billion in groundbreaking research supporting many of today’s most innovative approaches to treatment—helping those with blood cancer not only survive but also thrive.

ā€œMy first connection to Blood Cancer United’s mission starts with my dad. He was diagnosed with chronic lymphocytic leuk...
08/25/2026

ā€œMy first connection to Blood Cancer United’s mission starts with my dad. He was diagnosed with chronic lymphocytic leukemia (CLL) in 2002 at the age of 66 and passed away a year later, in 2003, from Richter’s transformation (RT).
My next connection is my niece, Courtney. She passed away at age 11 from acute myelomonocytic leukemia (AMML).
Then, in January 2017, my daughter was home from college on break, and we ordered pizza for dinner on Friday the 13th. The next day, my stomach was bothering me, but I figured it was the pizza. The pain didn’t go away, so I saw a doctor and had some tests. Although they initially thought I had diffuse large B-cell lymphoma (DLBCL), I was diagnosed with double-hit lymphoma (DHL). They recommended DA-EPOCH-R instead of R-CHOP, which meant I’d spend one week out of every three in the hospital for six to eight cycles.
While I was in treatment, I read about Blood Cancer United’s online patient community and joined. I was able to connect with people going through the exact same chemotherapy regimen, which was amazing and made me feel like I wasn’t alone.
I finished six cycles of treatment, was in remission by July 2017, and rang the bell.
Treatment took its toll; it took a while to regain my energy, stamina, and hair, I visited my daughter in Boston and took a picture of myself taking off my wig behind the MFA. She later spent a semester abroad in Valencia, Spain, so I was able to visit her and see Spain. I’d never been to Europe before, so I got my wish to stick my toes in the Mediterranean.
Later in 2018, I attended the Blood Cancer Conference in New York. In 2019, I joined an in-person Blood Cancer United support group at a local hospital and met survivors of many different blood cancers.
In early 2020, two things happened: COVID-19, and, for me, I got an email from a former colleague saying there was a data analytics opening in Advancement and asking if I was interested. It was my dream to join an organization that had helped me so much, so I joined the amazing Advancement team in May 2020. If that wasn’t enough, Blood Cancer United formed an employee resource group for cancer survivors. I had the good fortune to serve as a co-lead for two years. Through that experience, I got to meet so many wonderful, inspirational employee-survivors.
It took a couple more years, but I finally made it to Italy, which had always been a dream of mine. I’d also never been to the Caribbean, so I traveled to CuraƧao and swam with turtles.
I love the name change to Blood Cancer United and everything it represents. I especially appreciate its inclusiveness. I love our bold goal and hope to contribute many more years of life beyond the nine I’ve already been given.ā€
Joan, we are so grateful for you—for the way you show up and for the generosity with which you share your life and story with us. The next time you go swimming with the turtles in CuraƧao, we'd love an invitation. Your turn: What do you plan to do with more time?

08/24/2026

We’re so excited to see Palmer’s dream come to life!šŸ

Our Clinical Trial Support Center connects you with a free oncology nurse navigator through Carebox Connect.Fill out a s...
08/24/2026

Our Clinical Trial Support Center connects you with a free oncology nurse navigator through Carebox Connect.

Fill out a short form and a nurse navigator will follow up to help you understand your options, review potential eligibility, and guide you through next steps.

Get started here ā¤µļø
https://bcutd.org/4qTWVBO

šŸ“¢ Applications close September 30th. ​If you are a blood cancer survivor pursuing a vocational, trade, two-year, or four...
08/24/2026

šŸ“¢ Applications close September 30th. ​

If you are a blood cancer survivor pursuing a vocational, trade, two-year, or four-year undergraduate program, this one is for you. The Scholarship for Blood Cancer Survivors awards $7,500 to help you build the future you deserve.​

Since 2022, we have awarded more than 1,100 new and renewed scholarships to blood cancer survivors across the country. Don't wait, apply today ā¬‡ļø
https://bcutd.org/4zztGsP

08/22/2026

When Savannah was 11 days old, her parents noticed something was wrong. Doctors said it was nothing. They kept pushing.

A dermatologist knew right away. Testing confirmed their newborn had acute myeloid leukemia (AML).

Savannah's brothers, Logan and Matthew, then 7 and 5, never left her side. They spent countless hours in her hospital room reading to her, holding her, playing with her. When she rang the remission bell at 8 months old, they were right there celebrating bringing their baby sister home cancer free.

Today, Savannah is three, in remission, and fully obsessed with Moana and mac and cheese. Her brothers still show up for her, from holding her hand during routine blood work to walking beside her every year at their local Light The Night walk.

Her mom Sarah shares their story so no family ever has to feel alone in this.

If your family is navigating a pediatric blood cancer diagnosis, free resources built for kids and families like Savannah's are available here ā¤µļø
https://bcutd.org/4zuZRJY

08/22/2026

Breaking news: the U.S. Food and Drug Administration has approved iberdomide (Zenbexus) as part of a combination treatment for adults with multiple myeloma who've already had at least one prior treatment.

This is the first time the FDA has used a new approach to speed up how a therapy gets accelerated approval. Here, the FDA assessed if a patient’s disease responded to treatment when looking for evidence of whether cancer cells could be seen in bone marrow samples. We helped fund the foundational research on protein degraders behind this therapy.

Learn more about this new therapyšŸ‘‡
https://bcutd.org/4wIhL9y

strength shows up in unexpected ways. what comes to mind for you? āœšŸ’Œļøļø
08/21/2026

strength shows up in unexpected ways. what comes to mind for you? āœšŸ’Œļøļø

08/20/2026

A blood cancer diagnosis affects more than your body. Your mental wellness deserves the same attention.

If you're a young adult ages 18 to 39, order a free Mental Wellness Box from us. It's built for wherever you are in your experience.

Order yours ā¤µļø
https://bcutd.org/3QMyfhE

šŸŽ„ :

Meet Matthew Frank, MD, PhD, at Stanford University.His project aims to train the immune system to target the CD22 prote...
08/20/2026

Meet Matthew Frank, MD, PhD, at Stanford University.

His project aims to train the immune system to target the CD22 protein, which often plays an important role in non-Hodgkin lymphoma subtypes. Dr. Frank's team studies what happens after people receive this therapy, working to improve outcomes while lowering side effects.

This project is part of the more than 250 academic research projects funded through our multi-year grants portfolio, all aimed at getting you closer to better treatment options.

See the impact your support makes possible in our 2025 Annual Report ā¬‡ļø
https://bcutd.org/44qlBrV

AML isn't one disease, it's many. The latest findings from the Beat AMLĀ® Master Clinical Trial are a reminder that treat...
08/19/2026

AML isn't one disease, it's many. The latest findings from the Beat AMLĀ® Master Clinical Trial are a reminder that treatment should reflect that.

Researchers looked at whether shortening a common AML treatment schedule could work just as well for older patients. The answer: it depends. Patients with certain genetic mutations fared better on the longer, standard treatment schedule, while others did just as well either way.

It's a reminder that no two patients with AML are the same, and understanding what makes each case different is how you get closer to care that fits you.

"Our study shows that shortening treatment is not a one-size-fits-all solution for older patients with AML," says lead author Dr. Uma Borate of The Ohio State University Comprehensive Cancer Center.

Beat AML is nearing its 10-year milestone, and this is exactly the kind of question it was built to answer: care that fits you.

Read the full findings šŸ”Ž
https://bcutd.org/4hvnz2b

Address

Washington D.C., DC

Alerts

Be the first to know and let us send you an email when Blood Cancer United posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share